Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced its financial results and business highlights for the three- and nine-months ended September 30, 2018. As quoted in the press release: “We achieved continued positive momentum at Athenex in … Continued
The post Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update appeared first on Investing News Network.